Dunwoody‑based Insight Global plans to hire more than 1,700 workers in 2026 to scale AI services and build an early‑career technical pipeline.

Ohio State researchers say a CRISPR vaccine beat leishmaniasis in animals as U.S. clinicians report rising cases. The team is preparing human trials.

Novartis agreed to buy Myricx Bio for up to $1.5 billion, adding a novel ADC payload platform and underscoring the Boston‑area connections between small biotech and big pharma. The deal could reshape local hiring and partnership flows as programs move toward clinical development.